# A New Intervention to Improve Function in Veterans With Anxiety and Depression

> **NCT06188923** · PHASE2 · RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 84 (estimated)

## Conditions studied

- Anxiety and Depression

## Interventions

- **DRUG:** Pregnenolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06188923
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-14
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06188923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06188923, "A New Intervention to Improve Function in Veterans With Anxiety and Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06188923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*